Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have ...

The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.

A South Korean study has found that lowering the level of low-density lipoprotein cholesterol, also known as “bad cholesterol ...

Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) ...

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, ...

Nearly 1 in 3 people who should get screened for colorectal cancer don't. Sometimes it's about the cost, but often it's about ...

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...

The list of “biohacks” is extensive and includes extreme diets, supplement use, juicing, red light therapy, cold exposure in ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...